GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tyche Industries Ltd (BOM:532384) » Definitions » Investments And Advances

Tyche Industries (BOM:532384) Investments And Advances : ₹0.0 Mil (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Tyche Industries Investments And Advances?

Tyche Industries's Investments And Advances for the quarter that ended in Dec. 2024 was ₹0.0 Mil.


Tyche Industries Investments And Advances Historical Data

The historical data trend for Tyche Industries's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tyche Industries Investments And Advances Chart

Tyche Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tyche Industries Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tyche Industries Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Tyche Industries Business Description

Traded in Other Exchanges
N/A
Address
D. No. C-21/A, Road No.9, Film Nagar, Jubilee Hills, Hyderabad, TG, IND, 500 096
Tyche Industries Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing of bulk drug intermediates. Geographically, it derives a majority of its revenue from the Export business. The company is a manufacturer in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to the USA and Europe. Its business areas include API, Intermediates, Chiral Intermediates, Nutraceuticals, and CDMO. It operates in a single segment namely the manufacture of bulk drugs intermediates.

Tyche Industries Headlines

No Headlines